Tremfya OverviewGuselkumab, sold under the trade name Tremfya, is a monoclonal antibody against interleukin-23 used for the treatment of plaque psoriasis. Contents 1 Medical uses 2 Adverse effects 3 Pharmacology 3.1 Mechanism of action 3.2 Pharmacokinetics 4 Commercialization 4.1 Cost 4.2 Research and development 5 See also 6 References Medical uses Guselkumab is FDA approved to treat moderate to severe plaque psoriasis, and psoriatic arthritis in adults.&am...
Read more Tremfya Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Guselkumab
Recent Tremfya Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 100mg/ml
NDC Database Records for Tremfya: (1 result)Sorted by National Drug Code
- 57894-640 Tremfya 100 mg/ml Subcutaneous Injection by Janssen Biotech, Inc.